Abstract
Radiation doses (RD) to fingers, eyes, and whole body of the medical staff during 17 angiographic applications of I-131-Lipiodol in 11 patients with liver malignancies were assessed. An automatic injector reduced the high finger dose of 20 mSv / application to 5 mSv but yielded contamination problems. A new developed special container reduced the finger RD to < 10 μSv. Additional radiation protection equipment resulted in a significant dose reduction to the eyes from 90 μSv to < 5 μSv and to the whole body from 120 μSv to 20 μSv.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
London W. Primary hepatocellular carcinoma — etiology, pathogenesis and prevention. Hum Pathol 1981; 12: 1085–1097.
Maraj R, Kew MC, Hyslop RJ. Resectability rate of hepatocellular carcinoma in rural southern Africans. Br J Surg 1988; 75: 335–338.
Groupe d étude et de traitement du carcinome hepatocellulaire. A comparison of Lipiodol chemoembolisation and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1256–1261.
Livraghi T, Bolondi L, Lazzaroni S et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer 1992; 69: 925–929.
Bretagne JF, Raoul JL, Bourguet P et al. Hepatic artery injection of I-131-labeled Lipiodol. Part 2: Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 547–550.
Raoul JL, Guyader D, Bretagne JF et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994; 35: 1782–1787.
Leung WT, Lau WY, Ho S et al. Selective internal radiation therapy with intra-arterial Iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 1994; 35: 1313–1318.
Novell R, Hilson A and Hobbs K. Ablation of recurrent primary liver cancer using 113I-lipiodol. Postgrad Med J 1991; 67: 393–395.
Kobayashi H, Hidaka H, Kajiya Y et al. Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution. Acta Radiol [Diagn] 1986; 27: 139–147.
Yoo HS, Lee JT, Kim KW et al. Nodular hepatocellular carcinoma. Treatment with subseg-mental intraarterial injection of iodine-131-labeled oil. Cancer 1991; 68: 1878–1884.
Raoul JL, Bourguet P, Bretagne JF et al. Hepatic artery injection of I-131-labeled Lipiodol. Part 1: Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 541–545.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this paper
Cite this paper
Risse, J.H., Grunwald, F., Ponath, C., Biersack, H.J. (1999). Radiation Protection in I-131-Lipiodol Therapy in Liver Neoplasms. In: Bergmann, H., Köhn, H., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research XXIII. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8782-3_45
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8782-3_45
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9772-3
Online ISBN: 978-3-0348-8782-3
eBook Packages: Springer Book Archive